Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 7,950 shares at $86.40 ($683K) on 2024-04-30, disclosed to the SEC on 2024-04-30.
Scheduled sale ($683k) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.74 | 6,550 | $562K | 82.3% |
| 2 | $86.40 | 700 | $60K | 8.9% |
| 3 | $86.40 | 700 | $60K | 8.9% |
| Total | $85.86 avg | 7,950 | $683K | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |